Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Taken a punt and bought a few more at .65.
gla, must be news soon.
For RNS release go to :
https://www.londonstockexchange.com/news?tab=news-explorer
Chester.
DM Yes my thoughts too. Not even played, just nerves ...
I think we are being played into selling. Sells too small to be in the know.
I've been looking here:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=report.page
but not sure if this is where the first notification is made?
Looks like panic selling, which is understandable I suppose. Very difficult to sit and watch the price decline, but there is no official news yet. I’m trying to take comfort that Alkindi has already been approved in the UK, Germany and Israel. Still, can’t find any official news yet so I don’t think there’s a leak.
To be fair HL won't quote to buy either unless v small no. of shares ...
Has news come out or is people just selling for no reason
Has news come out or is people just selling for no reason
A number of small sells appear to be driving the sp down, hardly likely to be those in the know. Far outweighed by earlier buys.
A don't know what is on L2, anyone?
HL won't give a sell price right now.
HAPPY Waiting its a yes or no or a tweak .. Very tempted to add we got other bits in pipeline so no worries if it dont go our way .ON a no 50 percent drop on a yes 1 pound a share gla
I'm "on pins", waiting for DNL and KAT today !
I thought the usa markets open up at 1pm from pre market trading the also start releasing earning reports from this times well
Hi DMcG54
I'm sure all the Diurnal management and staff are all on pins.
Must be more nerve racking for them as well.
Lets be positive, its a fantastic new innovation and is a huge step up from what kiddies have to face with continual injections and the like. So given that DNL have done everything correct it would be wrong for the FDA to delay the process on a wrongly dotted i .
CityTTrader said we will probably have to wait for the US to wake up and then the FDA will issue their decision after 2.30pm which is probably correct. So I'm off out for four hours and will check back after 2.30pm.
Laters ............. : )
Chester.
I think the MMs are trying to spook the jelly legs to get some supply ahead of a + FDA result. Tricky chimps
Bloody peanut MMs are playing with the pricing, chimps
I'm going to have to lay off the coffee today. The FDA suspense is nail biting. GLA
Another article, nothing new really;
Another catalyst coming its way is the FDA decision on Alkindi Sprinkle, a taste-neutral granule formulation of hydrocortisone, expected on September 29, 2020.
Alkindi Sprinkle is proposed as replacement therapy for pediatric adrenal insufficiency (AI), including congenital adrenal hyperplasia (CAH) in infants to patients less than 17 years of age. Eton acquired U.S. marketing rights to Alkindi Sprinkle from Diurnal Group plc (DNL).
The market opportunity for Alkindi Sprinkle in the United States is estimated to be greater than $100 million annually. The product was approved in Europe in 2018 under the trade name Alkindi and is marketed by Diurnal in select countries throughout Europe.
Morning,
something to read while you are waiting;
https://www.pharmalive.com/fda-action-alert-aquestive-eton-and-mesoblast/
Good luck today